On Oct. 5, the National Institutes of Health announced the names of 106 scientists who have been awarded grants through the High-Risk, High-Reward Research program to advance highly innovative biomedical and behavioral research. Seven of the recipients are MIT faculty members. The High-Risk, High-Reward Research program catalyzes scientific discovery by supporting research proposals that, due to their inherent risk, may struggle…
Read More
Fellowship funding for graduate students fuels research at universities around the world, the MCO (Molecules, Cells, & Organisms) Program is no exception. G1 Maati McKinney was awarded fellowships by both the NSF Graduate Research Fellowship Program (GRFP) and the National GEM Consortium. Meanwhile, G4 Anastasia Repouliou of the Extavour Lab earned a Ph.D. Fellowship from the Boehringer Ingelheim Fonds, an independent, non-profit foundation based in Germany that promotes basic research in the…
Read More
Cancer researcher Madeleine Oudin has been named a New Innovator by the National Institutes of Health (NIH). The Tiampo Family Assistant Professor in the Department of Biomedical Engineering at Tufts, Oudin earned the honor for her research into a critical pathway to tumor growth. The award totals $2.3 million over five years. “This award will allow the lab to explore…
Read More
Philip Kranzusch, PhD of Dana-Farber Cancer Institute has received the New Innovator Award from the National Institutes of Health’s High-Risk, High-Reward Research program. The prestigious award supports exceptionally creative early career investigators pursuing highly innovative research with the potential for broad impact in biomedical, behavioral, or social sciences. Kranzusch, a Principal Investigator in the Cancer Immunology and Virology Department at Dana-Farber…
Read More
Dana-Farber Cancer Institute researchers are recipients of a new Movember – Prostate Cancer Foundation (PCF) Challenge Award. The $1 million award aims to support ambitious team science with the potential to develop new treatments for metastatic prostate cancer. Dana-Farber’s Matthew Freedman, MD, is principal investigator. Other Dana-Farber team members include Mark Pomerantz, MD, and Sylvan Baca, MD, PhD.   There are currently no curative treatment…
Read More
The Faculty Affairs Office is pleased to announce that C. James McKnight, PhD, is October’s Distinguished Faculty of the Month. Now an associate professor of physiology and biophysics, McKnight joined the BUSM community in 1995. He received a BS in chemistry from Washington College, Chestertown, Md.; master’s in chemistry & biochemistry from the University of Delaware; and PhD in biochemistry…
Read More
George Murphy, PhD, associate professor of medicine, and co-director of the Boston Medical Center/BU Center for Regenerative Medicine (CReM) is a recipient of a 2021 Healthy Longevity Catalyst Award for his project “Deciphering Mechanisms of Disease Resistance and Longevity in Centenarians.” The National Academy of Medicine (NAM) founded the competition and coordinates among a network of global collaborators, each administering…
Read More

Flaminia Catteruccia Named Howard Hughes Medical Institute Investigator

The Howard Hughes Medical Institute (HHMI) has named Flaminia Catteruccia, professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health, as one of 33 new HHMI investigators. HHMI will provide Catteruccia with about $9 million in support, including salary, benefits, and a research budget, over a seven-year term. This support will allow Catteruccia to pursue her scientific…
Read More

Toward Transformative Science

Four Harvard Medical School faculty members were named Howard Hughes Medical Institute Investigators on Sept. 23. They are among 33 individuals recognized as outstanding scientists working to solve some of the most challenging problems in biomedical research. HHMI selected the new investigators because they’re thoughtful, rigorous scientists who have the potential to make transformative discoveries over time, said David Clapham, HHMI’s vice president and…
Read More
The Transformative Scholars Program in the Department of Medicine at Massachusetts General Hospital was established to support talented physician-scientists in taking on critical challenges facing health and health care today. With the support of visionary philanthropists, the program provides the opportunity for outstanding young faculty to pursue innovative, high impact, interdisciplinary work. By linking the individual support to the world-class…
Read More